1.
Montgomery MS. Generics And Biosimilars: Mapping The Biosimilars Regulatory Approval Pathway Against The Hatch-Waxman Act And Projecting Futures Effects On The Biologics Market And Patent Protection. U. Pitt. L. Rev. [Internet]. 2015 May 21 [cited 2024 Apr. 28];75(3). Available from: http://lawreview.law.pitt.edu/ojs/lawreview/article/view/339